2025 annual financial data
Telix Pharmaceuticals 2025 Operating margin
Telix Pharmaceuticals 2025 operating margin with verified reported values.
Direct answer
Operating margin was 2.21%.
Operating income was 26,641,653 USD and net income was -10,685,154 USD.
Operating cash flow was -25,933,808 USD.
Get free Telix Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,205,426,458 USD
- Operating income
- 26,641,653 USD
- Net income
- -10,685,154 USD
- Operating cash flow
- -25,933,808 USD